Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular Carcinoma期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular Carcinoma

Authors:	Kenya Yoshida MD Yasuhiko Tomita MD Yorihide Okuda MD Shinji Yamamoto MD Hirayuki Enomoto MD Hirokazu Uyama MD Hiroaki Ito MD Yoshihiko Hoshida MD Katsuyuki Aozasa MD Hiroaki Nagano MD Masato Sakon MD Ichiro Kawase MD Morito Monden MD Hideji Nakamura MD

Affiliation:	(1) Department of Molecular Medicine, Osaka University Graduate School of Medicine, Yamada-oka 2-2, Suita Osaka, 565-0871, Japan;(2) Department of Pathology, Osaka University Graduate School of Medicine, Yamada-oka 2-2, Suita Osaka, 565-0871, Japan;(3) Department of Surgery and Clinical Oncology, Osaka University Graduate School of Medicine, Yamada-oka 2-2, Suita Osaka, 565-0871, Japan;(4) Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya Hyogo, 663-8501, Japan

Abstract:

Keywords:	Hepatoma-derived growth factor Hepatocellular carcinoma Prognosis Recurrence
本文献已被 PubMed SpringerLink 等数据库收录！